Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas
暂无分享,去创建一个
L. Akslen | G. Naumov | O. Straume | Lars A Akslen | George N Naumov | Ingeborg M Bachmann | Oddbjørn Straume | Rita G Ladstein | I. Bachmann | Rita G. Ladstein | Ingeborg M. Bachmann
[1] L. Akslen,et al. Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] Holger Moch,et al. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade , 2001, The Journal of pathology.
[3] M. Herlyn,et al. Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. , 2000, Journal of cell science.
[4] A. Harris,et al. Hypoxia Inducible Carbonic Anhydrase IX, Marker of Tumour: Hypoxia, Survival Pathway and Therapy Target , 2004, Cell cycle.
[5] F. Mitjans,et al. In vivo therapy of malignant melanoma by means of antagonists of alphav integrins. , 2000, International journal of cancer.
[6] F. Mitjans,et al. In vivo therapy of malignant melanoma by means of antagonists of αv integrins , 2000 .
[7] T. Koji,et al. Fas-Mediated Apoptosis of Melanoma Cells and Infiltrating Lymphocytes in Human Malignant Melanomas , 2002, Modern Pathology.
[8] K. Nakanishi,et al. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] M. Noda,et al. Osteopontin‐Deficiency Suppresses Growth of B16 Melanoma Cells Implanted in Bone and Osteoclastogenesis in Co‐Cultures , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] M. Nosrati,et al. Osteopontin as a molecular prognostic marker for melanoma , 2008, Cancer.
[11] A. Harris,et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] A. Baldi,et al. Role of Apaf‐1, a key regulator of apoptosis, in melanoma progression and chemoresistance , 2005, Experimental dermatology.
[13] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[14] A. Harris,et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. , 2001, Cancer research.
[15] P. Kincade,et al. CD44 and its interaction with extracellular matrix. , 1993, Advances in immunology.
[16] E. Mooney,et al. Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma. , 1995, Journal of clinical pathology.
[17] V. Kosma,et al. Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. , 2000, The American journal of pathology.
[18] L. Akslen,et al. Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma , 1997, International journal of cancer.
[19] A. Harris,et al. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .
[20] L. Akslen,et al. Angiogenesis is prognostically important in vertical growth phase melanomas. , 1999, International journal of oncology.
[21] W. Sly,et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. , 2001, The American journal of pathology.
[22] D. Elder,et al. Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. , 1998, The American journal of pathology.
[23] D. Lev,et al. Cellular Adhesion Pathways and Metastatic Potential of Human Melanoma , 2002, Cancer biology & therapy.
[24] L. Akslen,et al. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression. , 2002, The American journal of pathology.
[25] J. Simon,et al. High CD44 surface expression on primary tumours of malignant melanoma correlates with increased metastatic risk and reduced survival. , 1997, European journal of cancer.
[26] J. Heino,et al. αV integrin promotes in vitro and in vivo survival of cells in metastatic melanoma , 2004, International journal of cancer.
[27] P. Vaupel,et al. Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.
[28] L. Skoog,et al. Expression of CD40, CD44, bcl‐2 antigens and rate of cell proliferation on fine needle aspirates from metastatic melanoma , 2002, Cytopathology : official journal of the British Society for Clinical Cytology.
[29] M. Martinka,et al. Reduced Apaf-1 expression in human cutaneous melanomas , 2004, British Journal of Cancer.
[30] L. Akslen,et al. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. , 2001, The American journal of pathology.
[31] K. Niedojadło,et al. Apaf-1 expression in human cutaneous melanoma progression and in pigmented nevi. , 2006, Pigment cell research.
[32] F. Mitjans,et al. Alpha v integrin antagonists induce the disassembly of focal contacts in melanoma cells. , 2000, European journal of cell biology.
[33] P. Bonnier,et al. Overexpression of hypoxia‐inducible factor HIF‐1α predicts early relapse in breast cancer: Retrospective study in a series of 745 patients , 2005, International journal of cancer.
[34] E. Rofstad,et al. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. , 2005, Cancer research.
[35] A. Shilkaitis,et al. Beta3 integrin expression in melanoma predicts subsequent metastasis. , 1996, The Journal of surgical research.
[36] John Calvin Reed. Apoptosis-targeted therapies for cancer. , 2003, Cancer cell.
[37] A. Harris,et al. Hypoxia‐inducible factor‐1α in non small cell lung cancer: Relation to growth factor, protease and apoptosis pathways , 2004, International journal of cancer.
[38] R. Hofmann-Wellenhof,et al. CD44 and variants in melanocytic skin neoplasms , 1998, Journal of cutaneous pathology.
[39] A Breslow,et al. Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma , 1970, Annals of surgery.
[40] M. Ringuette,et al. Novel Functions of the Matricellular Proteins Osteopontin and Osteonectin/SPARC , 2002, Connective tissue research.
[41] G. Botti,et al. Analysis of APAF‐1 expression in human cutaneous melanoma progression , 2004, Experimental dermatology.
[42] D. Hedley,et al. Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation. , 2002, International journal of radiation oncology, biology, physics.
[43] D. Elder,et al. Progression-related expression of beta3 integrin in melanomas and nevi. , 1999, Human pathology.
[44] E. Raso,et al. Role for beta3 integrins in human melanoma growth and survival. , 2002, International journal of cancer.
[45] D. Denhardt. Osteopontin expression correlates with melanoma invasion. , 2005, The Journal of investigative dermatology.
[46] M. Herlyn,et al. Hsu M, Andl T, Li G, Meinkoth JL, Herlyn MCadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci 113: 1535-1542 , 2000 .
[47] K. Nakanishi,et al. Expression of Hypoxia-Inducible Factor-1α Protein Predicts Survival in Patients with Transitional Cell Carcinoma of the Upper Urinary Tract , 2005, Clinical Cancer Research.
[48] W. Clark,et al. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.
[49] L. Akslen,et al. Importance of P-Cadherin, β-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma , 2005, Clinical Cancer Research.
[50] Ichikawa,et al. Moesin and CD44 expression in cutaneous melanocytic tumours , 1998, The British journal of dermatology.
[51] E. Raso,et al. Role for β3 integrins in human melanoma growth and survival , 2002 .
[52] Karen D. Cowden Dahl,et al. Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression. , 2005, Molecular biology of the cell.
[53] J. Heino,et al. Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma. , 2004, Melanoma research.